Posted inBiogen Inc Centers for Medicare and Medicaid Services Drugs (Pharmaceuticals) Eisai Co Ltd Food and Drug Administration Labeling and Labels (Product) Medicare New England Journal of Medicine Placebos United States
F.D.A. Approves New Treatment for Early Alzheimer’s
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.